Arcellx, Inc. Files 8-K on Operations and Financials
Ticker: ACLX · Form: 8-K · Filed: May 8, 2025 · CIK: 1786205
| Field | Detail |
|---|---|
| Company | Arcellx, INC. (ACLX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
Arcellx filed an 8-K, expect more details on financials soon.
AI Summary
Arcellx, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as an official update from Arcellx, Inc. to the SEC regarding its financial health and operational performance, which is crucial for investors to assess the company's status.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain new material adverse information.
Key Players & Entities
- Arcellx, Inc. (company) — Registrant
- May 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 800 Bridge Parkway Redwood City, CA 94065 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific figures within this excerpt.
When was this 8-K filing submitted?
The filing was submitted on May 8, 2025.
What is Arcellx, Inc.'s state of incorporation?
Arcellx, Inc. is incorporated in Delaware.
What is the principal executive office address for Arcellx, Inc.?
The principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.
What is the SIC code for Arcellx, Inc.?
The Standard Industrial Classification (SIC) code for Arcellx, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Arcellx, Inc. (ACLX).